Reference
  1. Frustaci A, Petrosillo N, Ippolito G, Chimenti C. Transitory ventricular tachycardia associated with influenza A infection of cardiac conduction tissue. Infection 2016;44(3):353–6.
  2. Abdalla LF, Santos JHA, Barreto RTJ, Souza EME, D’Assunção FF, Borges MA, et al. Atrial fibrillation in a patient with Zika virus infection. Virol J 2018;15(1):23.
  3. Watanabe M, Panetta GL, Piccirillo F, Spoto S, Myers J, Serino FM, et al. Acute Epstein-Barr related myocarditis: an unusual but life-threatening disease in an immunocompetent patient. J Cardiol Cases 2020;21(4):137–40.
  4. Sardana M, Hsue PY, Tseng ZH, Vittinghoff E, Nah G, Dewland TA, et al. Human immunodeficiency virus infection and incident atrial fibrillation. J Am Coll Cardiol 2019;74(11):1512–4.
  5. Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med 2020 Aug 14;1-6, Online ahead of print.
  6. Beinart R, Morganti K, Ruskin J, Mela T. H1N1 influenza A virus induced atrioventricular block. J Cardiovasc Electrophysiol 2011;22(6):711–3.
  7. Lau S-T, Yu W-C, Mok N-S, Tsui P-T, Tong W-L, Cheng SWC. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS). Int J Cardiol 2005;100(1):167–9.
  8. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014;29:301–6.
  1. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmia complication in patients with COVID-19. J Cardiovasc Electriophysiol 2020;31(5):1003-8.
  2. Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020;59(2):329-36.
  3. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm 2020;17(9):1439-44.
  4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061-9.
  1. Kir D, Mohan C, Sancassani R. Heart Brake: An Unusual Cardiac Manifestation of COVID-19. JACC Case Rep 2020;2(9):1252-5.
  2. Ashok V, Loke WI. Case report: high-grade atrioventricular block in suspected COVID-19 myocarditis. Eur Heart J Case Rep 2020;4(FI1):1-6.
  3. Naksuk N, Lazar S, Peeraphatdit TB. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care 2020;9(3):215-21.
  4. Crotti L, Arbelo E. COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias. Heart Rhythm 2020;17(9):1423-4.
  5. Shekerdemian L, Bohn D. Cardiovascular effects of mechanical ventilation. Arch Dis Child 1999;80(5):475-80.
  6. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care 2005;9(6):607-21.
  7. Strong EB, Green JF. Multireceptor activation of the pulmonary chemoreflex. J Appl Physiol (1985) 1991;70(1):368-70.